Bristol-Myers Squibb to Acquire Celgene
The Scientists Behind the Science
Sharon Cload is vice president of Molecular Discovery Technology at our Cambridge, Mass., site.
Building Toward a Translational Future
Saurabh Saha leads the translational medicine team and returns to the Boston-area to build out the new R&D facility in Cambridge.
Emerging Trends in Immuno-Oncology: A Focus on Resistance
Bristol-Myers Squibb is underwriting a series in partnership with Scientific American, offering expert perspectives on the latest challenges and discoveries in Immuno-Oncology (I-O).
Scientists on the Move
As an R&D footprint expands, several colleagues saw an opportunity to explore new areas of science.
Science
Hacking R&D: The Role of Artificial Intelligence
Artificial intelligence may have the potential to help scientists solve complex research problems much faster than ever before.
Press Release
Bristol-Myers Squibb announces offer from Taisho Pharmaceutical Holdings Co., Ltd to purchase UPSA.
People
Standing Together for STEM
Bristol-Myers Squibb rolls out new approach to unify STEM initiatives.
Looking for Answers?
Quick links to helpful resources.